Navigation Links
Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting

o-controlled, repeat-dosing study designed to evaluate the clinical safety and clinical effects of repeat administration of SB-509 in diabetics with mild to moderate diabetic peripheral sensory motor neuropathy in the legs. The trial will be conducted at multiple sites.

Approximately 100 subjects will be enrolled into the trial. Subjects will be randomized to one of two groups in a 2:1 ratio. The larger group (approximately 66 subjects) will be treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into the lower limb every 2 months. The remaining group (approximately 33 subjects) will receive an equal volume of placebo on the same schedule. Each subject will receive a total of three treatments (Day 0, 60 and 120). Subjects will receive injections in a distribution pattern that targets the major peripheral nerves in the legs and feet.

The symptoms of diabetic peripheral neuropathy and any changes that occur during the trial will be evaluated based on neurological examination data, electrophysiological testing data, subject neurological questionnaire, and subject pain assessment. Specifically, investigators will use the following tests: the visual analog scale for pain intensity (VASPI), total neuropathy score (TNS) to assess signs and symptoms of the condition. A composite scoring system is widely regarded by neurologists as the most comprehensive approach to evaluating changes in nerve health. In addition to qualitative assessment of symptoms, the TNS includes electrophysiological testing using nerve conduction velocity (NCV) to assess the rate at which a nerve can conduct an electrical signal, and quantitative sensory testing (QST) with the Vibratron II instrument, to assess the threshold of detection of vibration. In addition, skin biopsies will be taken to evaluate the direct therapeutic effect of SB-509 on nerve regrowth. This test is a very sensitive marker of DN severity and may provide an important mechanistic marker fo
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
6. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:12/19/2014)... 2014  In the Friday, December 19 edition of ... Healthcare Information Technology (HIT) features Konica Minolta, the company announced today. ... with several leading healthcare organizations. In addition to ... markets, such as New York , ... , Minneapolis and San ...
(Date:12/19/2014)... Breckenridge Pharmaceutical, Inc. announced today that it ... Pvt. Ltd. ( Hyderabad, India ) under ... ANDAs.  Under the terms of the agreement, MSN will ... for the U.S. market, and Breckenridge will market and ... have agreed to develop an oral antibiotic with current ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, 2014 /PRNewswire/ ...  Sorrento), an oncology company developing new treatments for ... privately-held immuno-oncology company developing proprietary Neukoplast ® ... announced today that the companies have entered into ... CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for the treatment ...
Breaking Medicine Technology:USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5
... FARMINGDALE, N.Y., March 1, 2011 Misonix, Inc. ... company that designs, manufactures, and markets innovative, therapeutic, ... neurosurgery, laparoscopic surgery, and other surgical and medical ... the ROTH Capital 23rd Annual Growth Stock Conference ...
... ERES ), a global technology-driven provider of clinical ... organizations, announced today that the Nasdaq Stock Market has ... will trade on the Nasdaq Global Select Market under ... advised to make note of this trading symbol change. ...
Cached Medicine Technology:ERT to Change Trading Symbol to "ERT" Effective March 7, 2011 to Properly Align Business Brand 2
(Date:12/21/2014)... BellasDress.com offers a wide range of women’s ... announces its BellasDress Christmas Sale , offering big ... , BellasDress is a famous online supplier of women’s ... a series of promotions. The dress experts of the ... “We are proud of offering high quality wedding dresses ...
(Date:12/21/2014)... AngelWeddingDress.com’s new collection of 2015 spring wedding dresses was ... designs in this collection, and all of them are ... promises to provide the most fashionable designs to ... fashion trends come and go. If ladies have any ... is ready to assist. , “These new models ...
(Date:12/21/2014)... Recently, one of the best prom dresses online shops ... introduced its new collection of 2015 prom dresses, and ... its prom dresses & other fashionable designs, up to ... quality dress products and great customer services to its ... the best prom dresses online shops around the world ...
(Date:12/21/2014)... 2014 Serious Buyer, Andrew Hawley from ... Morrison and the Doors International Ballroom at the Hilton ... be the only time that Morrison's mother would see ... 25, 1967. According to Hawley, “This would be the ... the Alexandria Roller Rink earlier that year and would ...
(Date:12/21/2014)... 21, 2014 SCI explores ... issues and systemic barriers for disabled athletes with ... Scheidies has a condition called juvenile macular degeneration, where ... how he adapted his athletic ambitions to his vision ... in triathlon to pioneer the way for other blind ...
Breaking Medicine News(10 mins):Health News:BellasDress.com Announces its BellasDress Christmas Sale 2Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3
... Commission has instituted a rule that doctors can no ... despite protests from lawyers and several doctors' groups. //Since ... misconduct by doctors and physician assistants and says that ... disciplinary action being taken. ,But the Commission ...
... out simultaneous raids on some government hospital doctors and ... Monday.// ,The raids were conducted in Chennai, Goa, ... the investigating agency said., ,The houses of Sudha ... Goel of Sucheta Kriplani Hospital here were searched, he ...
... is being tried in the Asia Pacific region, says drug ... in the US and further testing on a few hundred ... year, Dr. Hans L. Bock told the Straits Times. ... fast, given that this is an issue of major public ...
... at a leading National Health Services (NHS) trust will be moved ... to save tens of millions of pounds on hospital beds in ... 100 patients suffering from cancer or blood disorders at University College ... the Radisson Edwardian Grafton, a four-star hotel where rooms cost ?168 ...
... 350 crore to add 1,800 beds over the next 18 ... Group's total capacity would touch 7,200 beds, from the current ... 800 beds through management of hospitals and another 1,000 beds ... said here on the sidelines of India Health Summit organised ...
... U.S. Food Drug Administration (US FDA) has approved ... mg.// ,Cephalexin is used to treat many ... tonsillitis, ear infections, skin infections, and urinary tract ... obtaining the first product approval from the dedicated ...
Cached Medicine News:Health News:Hospital Cuts Costs By Moving Cancer Patients To Hotels 2
This advanced digital monitor detects the appearance of an irregular heartbeat during measurement and gives a warning signal with your reading. An irregular heartbeat may cause or indicate cardiovasc...
... Through its unique and patented ... wires and trunk cables between patients ... monitors, allowing freedom of movement throughout ... technology, the LifeSync(R) System employs two-way ...
Inquire...
... STA Compact is ... access coagulation analyser for ... latex based .coagulation tests.The ... loading of primary tubes, ...
Medicine Products: